Skip to content

ANGIOTECH PHARMACEUTICALS INC

CIK 0001096481

← back to feed
Revenue (TTM)
$235.92M
+59.4% YoY FY Mar 2013
Net Income (TTM)
—
FY Mar 2013
EPS Diluted (TTM)
−$2.37
FY Mar 2013
Gross Margin
40.2%
FY Mar 2013
Operating Margin
0.0%
FY Mar 2013
Net Margin
—
FY Mar 2013
Free Cash Flow (TTM)
—
FY Mar 2013
Cash
$45.95M
FY Mar 2013
Total Debt
$289.44M
FY Mar 2013
Shares Outstanding
12.55M sh
FY Mar 2013

Revenue & Net Income

Margins

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings